MONTHLY PROGRESS REPORT July 2016 Form 7 MONTHLY PROGRESS REPORT July 2016
Name of CSE Issuer THC BioMed Intl Ltd. Trading Symbol:
THC Number of Outstanding Listed Securities 96,199,544 common shares and 22,176,250 reserved for Issuance
Date: August 4, 2016
Report on Business
1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact. During the past month, the Issuer generally continued to develop technology products related to genetic development.
2. Provide a general overview and discussion of the activities of management. Management continued to develop the business of the Issuer. This included ongoing work with on the development and expansion of its propagation and cloning vertical Seeds R Us. Management has opened a call center as it expects increased activity within its inbound call center. Management has entered into negotiations to lease extra space for administrative purpose. The issuer has entered an agreement to purchase 85 kg of dried marihuana from another licensed producer. The issuer has already paid for 25kg and expects the first shipment of 25kg to be delivered soon.
3. Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production programs and acquisitions of any new properties and attach any mineral or oil and gas or other reports required under Ontario securities law. The issuer has begun the development of “THC Cultivator” an in home grow system that when combined with auto flowering strains allows home growers (where permitted) to grow marihuana at home safely and effortlessly. The issuer has begun the manufacture of its own fertilizers.
